Alberta Health Services. (2016, February). Oral Cavity Cancer Clinical Practice Guideline HN-002.
American Cancer Society. (2016, August 8). Oral Cavity and Oropharyngeal Cancer.
Cancer Care Ontario. (2009, December 15). Evidence-Based Series 5-3: The Management of Head and Neck Cancer in Ontario.
Cancer Care Ontario. (2015, March 17). Evidence-Based Series 5-12: Epidermal Growth Factor Receptor (EGFR) Targeted Therapy in Stage III and IV Head and Neck Cancer. (Version 3 Édition).
Cancer Care Ontario. (2004, December). Evidence-Based Series 5-10 Section 1: The Role of Postoperative Chemoradiotherapy for Advanced Squamous Cell Carcinoma of the Head and Neck: A Clinical Practice Guidline.
Cancer Care Ontario. (2016, August 10). Practice Guideline 5-11: Systemic Therapy in the Curative Treatment of Head and Neck Squamous Cell Cancer.
Cancer Research UK. (2016, June 21). The Mouth and Oropharynx.
Koch WM, Stafford E, Chung C, Quon H. Cancer of the oral cavity. Harrison LB, Sessions RB, Kies MS. (2014). Head and Neck Cancer: A Multidisciplinary Approach. (4th Édition). Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins. 16A:335-356.
National Cancer Institute. (2016, August 19). Lip and Oral Cavity Cancer Treatment (PDQ®).
National Cancer Institute. (2015, September 25). Lip and Oral Cavity Cancer Treatment for Health Professionals (PDQ®).×